Rokiskio Suris AB (VSE:RSU1L)

Market Cap	128.19M
Revenue (ttm)	370.35M
Net Income (ttm)	22.84M
Shares Out	31.42M
EPS (ttm)	0.75
PE Ratio	5.46
Forward PE	n/a
Dividend	0.20 (4.90%)
Ex-Dividend Date	May 14, 2025

Volume	189
Average Volume	340
Open	4.080
Previous Close	4.100
Day's Range	4.080 - 4.100
52-Week Range	3.040 - 4.800
Beta	0.10
RSI	52.65
Earnings Date	Aug 29, 2025

About Theseus Pharmaceuticals

Rokiskio Suris AB engages in the production and sale of fermented cheese, whey, and skimmed milk powder products in Lithuania. The company operates in two segments, Fresh Milk Products, and Cheese and Other Dairy Products. It also provides fresh milk products, such as milk, butter milk, kefir, cream, sour milk, cottage cheese, yogurt, curd, curd cheese, sour cream, glazed cheese, desserts, hard cheese, and semi-hard cheese products, as well as purchases raw milk. The company also exports its products to 54 countries worldwide. Rokiskio Suris AB...

• Industry: Dairy Products
• Founded: 1925
• Employees: 1,200
• Stock Exchange: Nasdaq Vilnius
• Ticker Symbol: RSU1L

Financial Performance

In 2024, Rokiskio Suris AB's revenue was 370.35 million, an increase of 21.72% compared to the previous year's 304.25 million. Earnings were 22.84 million, an increase of 40.64%.